Viewing StudyNCT00251355



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00251355
Status: COMPLETED
Last Update Posted: 2016-12-20
First Post: 2005-11-08

Brief Title: Gemcitabine 5-Fluorouracil and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer
Sponsor: Dana-Farber Cancer Institute
Organization: Dana-Farber Cancer Institute

Organization Data

Organization: Dana-Farber Cancer Institute
Class: OTHER
Study ID: 97-105
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Dana-Farber Cancer Institute
Lead Sponsor Class: OTHER
Responsible Party: Charles S Fuchs MD
Responsible Party Title: Principal Investigator
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Dana-Farber Cancer Institute
Old Name: None
Old Organization: None

Collaborators

Name Class
Massachusetts General Hospital OTHER
Brigham and Womens Hospital OTHER